Lipella Pharmaceuticals earnings were -$4.1M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest LIPO earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$938.1k, down 21.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, LIPO reported annual earnings of -$4.6M, with 77.8% growth.
Lipella Pharmaceuticals Earnings Reports & History FAQ
What were Lipella Pharmaceuticals's earnings last quarter?
Lipella Pharmaceuticals (NASDAQ: LIPO) reported Q2 2024 earnings per share (EPS) of -$0.12, up 55.56% year over year. Total LIPO earnings for the quarter were -$938.15 thousand. In the same quarter last year, Lipella Pharmaceuticals's earnings per share (EPS) was -$0.27.
Is Lipella Pharmaceuticals profitable or losing money?
As of the last Lipella Pharmaceuticals earnings report, Lipella Pharmaceuticals is currently losing money. Lipella Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$4.14 million, a 12.44% increase year over year.
What was LIPO's earnings growth in the past year?
As of Lipella Pharmaceuticals's earnings date in Q4 2024, Lipella Pharmaceuticals's earnings has grown year over year. LIPO earnings in the past year totalled -$4.14 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.